Chemours Co. Enters Material Definitive Agreement
Ticker: CC · Form: 8-K · Filed: 2025-10-16T00:00:00.000Z
Sentiment: neutral
Topics: material-agreement, financial-obligation
TL;DR
Chemours signed a big deal on Oct 13th, creating new financial obligations.
AI Summary
On October 13, 2025, The Chemours Company entered into a material definitive agreement. This agreement also created a direct financial obligation for the company. The specific details of the agreement and the financial obligation are not fully disclosed in this filing.
Why It Matters
This filing indicates a significant new agreement for Chemours, which could impact its financial obligations and future business operations.
Risk Assessment
Risk Level: medium — Entering into material definitive agreements and creating new financial obligations can introduce financial and operational risks that are not yet fully understood.
Key Players & Entities
- The Chemours Company (company) — Registrant
- October 13, 2025 (date) — Date of Earliest Event Reported
- Delaware (jurisdiction) — State of Incorporation
- 1007 Market Street Wilmington, Delaware 19801 (address) — Principal executive offices
- (302) 773-1000 (phone_number) — Registrant's telephone number
FAQ
What is the nature of the material definitive agreement entered into by Chemours?
The filing states that Chemours entered into a material definitive agreement on October 13, 2025, but does not provide specific details about the agreement's terms or counterparty.
What type of direct financial obligation was created for Chemours?
The filing indicates the creation of a direct financial obligation as a result of the agreement, but the specific nature and amount of this obligation are not detailed.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this filing occurred on October 13, 2025.
What is Chemours' state of incorporation?
The Chemours Company is incorporated in Delaware.
Where are Chemours' principal executive offices located?
Chemours' principal executive offices are located at 1007 Market Street, Wilmington, Delaware 19801.
From the Filing
0001193125-25-240643.txt : 20251016 0001193125-25-240643.hdr.sgml : 20251016 20251015211725 ACCESSION NUMBER: 0001193125-25-240643 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20251013 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Other Events FILED AS OF DATE: 20251016 DATE AS OF CHANGE: 20251015 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chemours Co CENTRAL INDEX KEY: 0001627223 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 464845564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36794 FILM NUMBER: 251396274 BUSINESS ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 302 773 1000 MAIL ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Chemours Company, LLC DATE OF NAME CHANGE: 20141205 8-K 1 cc-20251014.htm 8-K 8-K false 0001627223 0001627223 2025-10-14 2025-10-14       UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   October 13, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter)   Delaware   001-36794   46-4845564 (State or Other Jurisdiction   (Commission   (I.R.S. Employer Of Incorporation)   File Number)   Identification No.)   1007 Market Street Wilmington , Delaware 19801 (Address of principal executive offices)   Registrant’s telephone number, including area code: (302) 773-1000   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of Each Class   Trading Symbol(s)   Name of Exchange on Which Registered Common Stock ($0.01 par value)   CC   New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐       Item 1.01 Entry into a Material Definitive Agreement. On October 15, 2025 (the “Amendment No. 4 Effective Date”), The Chemours Company (the “Company”) entered into Amendment No. 4 (the “Amendment”) by and among the Company, The Chemours Company FC, LLC, the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent (the “Administrative Agent”), which amends the Second Amended and Restated Credit Agreement, dated as of August 18, 2023, among the Company, the lenders from time to time party thereto and the Administrative Agent (